Australian (ASX) Stock Market Forum

IMC - Immuron Limited

Jump to new
System

System

Joined
27 June 2010
Posts
4,147
Reactions
309
Immuron Limited (IMC) is a biopharmaceutical company in Australia. IMC's product ranges target infectious diseases of the gastrointestinal tract, chronic diseases such as fatty liver (NASH), and prevention of influenza. IMC currently has one product in the market and seven products under research and development process.

http://www.immuron.com
 
Immuron Limited doing well over the last few days. Heavy volume today and share price up 9.5c to 48.5c.

screenshot-shareinvesting.anz.com-2018-03-13-11-25-55.png
 
IMC is developing some cutting edge immunotherapies. Showing a volatile but slow uptrend and can jump on any positive results as it did on 8th of March when reported +ve results of a clinical trial.
 
Immuron reports positive results from Travelan testing, develops anti-dysentery vaccine products

Australian biopharmaceutical company Immuron (ASX: IMC) has reported positive results from a study designed to test the efficacy of Travelan anti-dysentery medication on non-human primates.


The placebo-controlled Shigellosis challenge study was conducted by the US Armed Forces Research Institute of Medical Sciences under a co-operative research and development agreement which Immuron has in place with the US Department of Defence.


It was designed to determine the potential of Travelan as a preventative treatment for US military personnel and civilians stationed or travelling in locations around the world where such infections may be debilitating. More...
 
These Biotech stocks are great for a heart malfunction, up few hundred % in a day and down 70%+ on another day... :doctor:

Would've been nice to have been in IMC yesterday though :hungry:
 
mordrax said:
I did a quick scalp of IMC on Tuesday.
I jumped in at 93 cents and then out at 88!
Then I called it a day.
Click to expand...

You'd be glad you got out at 88c !

It's turning out to be a wild ride, which is usually the case with Biotech stocks in my experience as I mentioned earlier.
 
G'day to all the biotech experts at ASF (@Knobby22 et al),

Is there some validity/potential to their claims that caused the share price to spike to hit 90c a couple of months back ?

1600231379494.png


Price has slowly drifted back down to around a third of that 90c spike as I write...

1600231495522.png

Any good ?
 
Using milk powder as a placebo?
Increases cell viability - what does that even mean?

Compare this to SPLs announcements with a similar product which is being released into first half market next year. Proven effective.

I would be careful.
(First impression only, haven't looked closely at the company).
 
I have had a closer look. Their products deal with gut bacterial infections and they have a traveller's product that is meant to help control diarrhoea.
They are in phase 2 testing with US Defence. One has failed, more candidates though.

Just had a raising as running out of cash.

I can't see how their products would have much effect on Covid except maybe inflammation.
 
Knobby22 said:
I have had a closer look. Their products deal with gut bacterial infections and they have a traveller's product that is meant to help control diarrhoea.
They are in phase 2 testing with US Defence. One has failed, more candidates though.

Just had a raising as running out of cash.

I can't see how their products would have much effect on Covid except maybe inflammation.
Click to expand...
Thanks for having a deeper look at it @Knobby22 :xyxthumbs
 
Just had a look myself and came to similar conclusion to @Knobby22 . The coronavirus isn't associated with gut problems. It's a respiratory pathogen. While it's interesting that it does prevent the virus from replicating in the gut it's not doing anything to the virus in the respiratory tract.

The chart is a classic "pump and dump" example that's seen in the charts of a few biotech and oil/gas drillers. It's no wonder that frustrated long term holders took advantage of the CV news to sell their holdings at much higher prices.

IMC does have something worthwhile if it works as intended (stopping travelers' diarrhoea).
 
peter2 said:
Just had a look myself and came to similar conclusion to @Knobby22 . The coronavirus isn't associated with gut problems. It's a respiratory pathogen. While it's interesting that it does prevent the virus from replicating in the gut it's not doing anything to the virus in the respiratory tract.

The chart is a classic "pump and dump" example that's seen in the charts of a few biotech and oil/gas drillers. It's no wonder that frustrated long term holders took advantage of the CV news to sell their holdings at much higher prices.

IMC does have something worthwhile if it works as intended (stopping travelers' diarrhoea).
Click to expand...
Thanks @peter2. I think a lot of spec firms have gotten on the COVID band wagon to toot their horn and attract some attention. Some may be more legitimate than others, but this one looks to be just smoke without a fire ?, if it's fallen this far from the spike, looks like there is little chance of re-igniting it with news flow... :cautious:
 
Top